Jeffrey S. Abrams

13.7k total citations · 1 hit paper
104 papers, 4.4k citations indexed

About

Jeffrey S. Abrams is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Jeffrey S. Abrams has authored 104 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 33 papers in Cancer Research and 18 papers in Genetics. Recurrent topics in Jeffrey S. Abrams's work include Breast Cancer Treatment Studies (20 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Cancer Treatment and Pharmacology (14 papers). Jeffrey S. Abrams is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Cancer Treatment and Pharmacology (14 papers). Jeffrey S. Abrams collaborates with scholars based in United States, Canada and Belgium. Jeffrey S. Abrams's co-authors include Edward L. Korn, Larry Norton, Hyman B. Muss, Martine Piccart, Boris Freidlin, Joseph L. Pater, Nicholas J. Robert, Kathleen I. Pritchard, Dongsheng Tu and Robert B. Livingston and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jeffrey S. Abrams

102 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

2005 818 citations Paul E. Goss, James N. Ingle et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Jeffrey S. Abrams

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Abrams more than expected).

Fields of papers citing papers by Jeffrey S. Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Abrams. The network helps show where Jeffrey S. Abrams may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Abrams. A scholar is included among the top collaborators of Jeffrey S. Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Abrams. Jeffrey S. Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PHOSPHOLAMBAN MUTATION LEADING TO RECURRENT SHORT-COUPLED POLYMORPHIC VENTRICULAR TACHYCARDIA AND FIBRILLATION IN PATIENT WITHOUT APPARENT STRUCTURAL HEART DISEASE 2023 ·Journal of the American College of Cardiology ·Jeffrey S. Abrams, Geoffrey S. Pitt, Olivier Elemento, Jim W. Cheung	1
2	Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding–deficient channels 2020 ·JCI Insight ·Jeffrey S. Abrams, Daniel Roybal, (unknown), Alexander N. Katchman, Richard L. Weinberg, Lin Yang, Bi-Xing Chen, Sergey I. Zakharov, Jessica A. Hennessey, Uma Mahesh R. Avula, (unknown), Chaojian Wang, Elaine Y. Wan, Geoffrey S. Pitt, Manu Ben‐Johny, Steven O. Marx	16
3	Proteolytic cleavage and PKA phosphorylation of α _1C subunit are not required for adrenergic regulation of Ca _V 1.2 in the heart 2017 ·Proceedings of the National Academy of Sciences ·Alexander N. Katchman, Lin Yang, Sergey I. Zakharov, Jared Kushner, Jeffrey S. Abrams, Bi-Xing Chen, Ao Liu, Geoffrey S. Pitt, Henry M. Colecraft, Steven O. Marx	31
4	National Cancer Institute's Precision Medicine Initiatives for the New National Clinical Trials Network 2014 ·American Society of Clinical Oncology Educational Book ·Jeffrey S. Abrams, Barbara A. Conley, Margaret Mooney, James A. Zwiebel, Alice P. Chen, John J. Welch, Naoko Takebe, Shakun Malik, Lisa M. McShane, Edward L. Korn, Mickey Williams, Louis M. Staudt, James H. Doroshow	122
5	Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for Integrating Biomarkers into Clinical Development of New Therapies for Lung Cancer Leading to the Inception of “Master Protocols” in Lung Cancer 2014 ·Journal of Thoracic Oncology ·Shakun Malik, Richard Pazdur, Jeffrey S. Abrams, Mark A. Socinski, William T. Sause, David H. Harpole, John J. Welch, Edward L. Korn, Claudio Dansky Ullmann, Fred R. Hirsch	18
6	Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers 2013 ·JNCI Journal of the National Cancer Institute ·(unknown), Boris Freidlin, Edward L. Korn, Barbara A. Conley, Jeffrey S. Abrams, Lisa M. McShane	101
7	Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006 2012 ·Neuro-Oncology ·K. Robin Yabroff, (unknown), Christopher A. Zeruto, Jeffrey S. Abrams, Bhupinder Mann	71
8	Noxious Menu: Chemically Protected Insects in the Diet of Caracara cheriway (Northern Crested Caracara) 2007 ·Southeastern Naturalist ·Joan L. Morrison, Jeffrey S. Abrams, Mark Deyrup, Thomas Eisner, (unknown)	4
9	Chapter 2: Dissemination of Adjuvant Multiagent Chemotherapy and Tamoxifen for Breast Cancer in the United States Using Estrogen Receptor Information: 1975-1999 2006 ·JNCI Monographs ·Angela B. Mariotto, Eric J. Feuer, Linda C. Harlan, Jeffrey S. Abrams	49
10	Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 breakdown → 2005 ·JNCI Journal of the National Cancer Institute ·Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Joseph L. Pater	818
11	Inflammatory Breast Issue 2003 ·JNCI Journal of the National Cancer Institute ·C. Norman Coleman, Paul E. Wallner, Jeffrey S. Abrams	3
12	North American Adjuvant Breast Cancer Trials 1998 ·Recent results in cancer research ·Jeffrey S. Abrams	7
13	Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial. 1995 ·Journal of Clinical Oncology ·Jeffrey S. Abrams, D. Vena, Janet H. Baltz, (unknown), Michael Montello, Michaele C. Christian, N Onetto, (unknown), Renzo Canetta, Michael Friedman	111
14	The National Cancer Institute Audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06 1995 ·New England Journal of Medicine ·Michaele C. Christian, Mary S. McCabe, Edward L. Korn, Jeffrey S. Abrams, Richard Kaplan, Michael Friedman	54
15	Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. 1993 ·Journal of Clinical Oncology ·Alice B. Kornblith, Donna Hollis, E Zuckerman, Alan P. Lyss, G P Canellos, M. Robert Cooper, James E. Herndon, (unknown), Jeffrey S. Abrams, Joseph Aisner	67
16	Phase I/II Study of Cyclophosphamide, Doxorubicin, Fluorouracil, and Leucovorin for Treatment of Metastatic Adenocarcinoma 1991 ·JNCI Journal of the National Cancer Institute ·Howard L. Parnes, Jeffrey S. Abrams, Nancy Tait, (unknown), Steven L. Allen, David B. Duggan, Joseph Aisner	5
17	High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell Carcinoma 1990 ·JNCI Journal of the National Cancer Institute ·Jeffrey S. Abrams, Anthony A. Rayner, P H Wiernik, David Parkinson, Mario A. Eisenberger, (unknown), Rasim Gucalp, M.B. Atkins, Michael Hawkins	57
18	Gonadotropin hormone - Releasing hormone analogs for the treatment of prostatic cancer 1988 ·Drugs of today ·Mario A. Eisenberger, Jeffrey S. Abrams	3
19	Intraperitoneal Chemotherapy With Cisplatin and Melphalan 1988 ·JNCI Journal of the National Cancer Institute ·Martine Piccart, Jeffrey S. Abrams, P. Dodion, (unknown), Jean‐Paul Sculier, J C Pector, (unknown), (unknown), (unknown), Ghanem Atassi, Y. Kenis	16
20	Clinical and pharmacokinetic phase I trial with the diethylaminoester of flavone acetic acid (LM985, NSC 293015) 1987 ·European Journal of Cancer and Clinical Oncology ·P. Dodion, Jeffrey S. Abrams, B. Gérard, (unknown), (unknown), (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact